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Particles suspended in the air are inhaled during normal respiration and unless
cleared by airway defences, such as the mucociliary transit (MCT) system, they
can remain and affect lung and airway health. Synchrotron phase-contrast X-ray
imaging (PCXI) methods have been developed to non-invasively monitor the
behaviour of individual particles in live mouse airways and in previous studies
the MCT behaviour of particles and ﬁbres in the airways of live mice after
deposition in a saline carrier ﬂuid have been examined. In this study a range of
common respirable pollutant particles (lead dust, quarry dust and ﬁbreglass
ﬁbres) as well as marker particles (hollow glass micro-spheres) were delivered
into the trachea of live mice using a dry powder insufﬂator to more accurately
mimic normal environmental particulate exposure and deposition via inhalation.
The behaviour of the particles once delivered onto the airway surface was
tracked over a ﬁve minute period via PCXI. All particles were visible after
deposition. Fibreglass ﬁbres remained stationary throughout while all other
particle types transited the tracheal surface throughout the imaging period. In
all cases the majority of the particle deposition and any airway surface activity
was located close to the dorsal tracheal wall. Both the individual and bulk
motions of the glass bead marker particles were visible and their behaviour
enabled otherwise hidden MCT patterns to be revealed. This study veriﬁed the
value of PCXI for examining the post-deposition particulate MCT behaviour
in the mouse trachea and highlighted that MCT is not a uniform process as
suggested by radiolabel studies. It also directly revealed the advantages of dry
particle delivery for establishing adequate particulate presence for visualizing
MCT behaviour. The MCT behaviour and rate seen after dry particle delivery
was different from that in previous carrier-ﬂuid studies. It is proposed that dry
particle delivery is essential for producing environmentally realistic particle
deposition and studying how living airway surfaces handle different types of
inhaled particles by MCT processes.
Keywords: particles; pollution; airway surface; lung; trachea; mucociliary transit;
non-invasive; X-ray imaging; phase contrast; mouse.
1. Introduction and objectives
Airborne pollutants suspended in the air in liquid, gaseous or
solid forms are a considerable health concern (Happo et al.,
2010). We have previously described new techniques for
imaging solid particulates and ﬁbres such as quarry dust,
ﬁbreglass, asbestos and lead in the nasal airways (Donnelley et
al., 2009) and trachea (Donnelley, Siu et al., 2010) of live
anaesthetized mice. These pollutants have the potential to
produce acute health effects and can impact on respiratory
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diseases such as cystic ﬁbrosis (CF), asthma, bronchitis and
emphysema as well as respiratory allergies and heart disease
(O’Connor et al., 2008). For example, CF patients living in
regions with high-particulate-matter air pollution, such as in
metropolitan areas, exhibit decreased lung function as well as
an increased risk of pulmonary exacerbations (Goss et al.,
2004). The manner in which particulates deposit onto the
airway surface and their behaviour after deposition remain
poorly understood, but are likely to inﬂuence or predict key
aspects of their subsequent pathophysiology.
Inhaled particles are cleared from the airways by muco-
ciliary transit (MCT) and the effectiveness of the MCT system
is a diagnostic indicator of airway health. To determine the
efﬁcacy of genetic (Stocker et al., 2009; Limberis et al., 2002)
and other potential therapies for CF airway disease in animal
models and potentially in humans we have developed novel
MCT monitoring methods, based on measuring the transit rate
and behaviour of individual deposited particles, that can be
used in vivo in mice (Donnelley et al., 2009; Donnelley, Siu
et al., 2010). By comparison, conventional methods for
measuring bulk particle clearance from the airways (Grubb et
al., 2004; Donaldson et al., 2007; Livraghi & Randell, 2007;
Hua et al., 2010) are unable to non-invasively detect and track
the motion of individual pollutant particles in real time or with
high resolution. Direct non-invasive visualization of the
behaviour of deposited particles in animal-model airways will
further improve our understanding of the MCT of individual
particles that could contribute to a better understanding of
airway health and disease.
Phase-contrast X-ray imaging (PCXI) is particularly useful
for producing enhanced soft tissue contrast where the
absorption differences are small, since it utilizes X-ray
refraction in addition to conventional absorption. Provided
the X-ray beam has sufﬁcient spatial coherence and the
sample-to-detector distance is sufﬁciently long (Snigirev et
al., 1995; Cloetens et al., 1996; Wilkins et al., 1996), tissue
boundaries are enhanced by the phase changes induced by
differences in their X-ray refractive indices. Our group has
already shown the beneﬁts of PCXI for non-invasive airspace
imaging in small animals (Parsons et al., 2008), for non-inva-
sive particulate detection in live mouse airways (Donnelley et
al., 2009; Donnelley, Siu et al., 2010; Siu et al., 2008) and for the
visualization of ﬂuid dosing for gene therapy treatments in live
mice (Donnelley et al., 2011).
Our previous studies (Donnelley et al., 2009; Donnelley, Siu
et al., 2010) delivered particulates in a 15 ml to 50 ml bolus of
0.9% saline carrier ﬂuid, a standard delivery method for
respiratory studies in mice (Helms et al., 2010). Using this
method it was only possible to deliver small quantities of
particulates (typically 1% w/v) because larger concentrations
fell out of suspension extremely rapidly. It is also likely that
the accompanying carrier ﬂuid perturbed the airway surface
and altered both the manner of deposition and the post-
deposition MCT behaviour being measured. Furthermore,
instillation tends to target the distal regions of the lung and
parenchyma compared with the upper respiratory tract where
most particulate deposition naturally occurs (Helms et al.,
2010).
The aim of this study was to verify that synchrotron PCXI
could be used to detect, monitor and compare the deposition
and transit behaviour of individual and groups of pollutant
particles after dry deposition into the trachea of live mice, to
better mimic environmental pollutant particle exposure. Using
a dry powder insufﬂator, and commonly inhaled pollutants, we
sought to document particle and ﬁbre visibility and post-
deposition MCT behaviour on the tracheal airway surface. We
also aimed to determine whether the dry delivery method
resulted in different post-deposition behaviour compared with
the saline carrier method used previously (Donnelley et al.,
2009; Donnelley, Siu et al., 2010).
2. Methods
Experiments were performed on the BL20XU undulator
beamline at the SPring-8 synchrotron radiation facility in
Japan, under approval from the Animal Ethics Committee of
SPring-8 and of the Women’s and Children’s Health Network,
Adelaide.
2.1. Imaging set-up
The experimental hutch was located in the Biomedical
Imaging Centre, 245 m from the storage ring, and the imaging
layout was as used previously (Parsons et al., 2008). Mono-
chromatic 25 keV ( = 0.5 A˚) X-rays were selected using a
standard double-crystal monochromator (Yabashi et al., 1999).
At the imaging station the beam size was approximately 4 mm
(H) 2 mm (V). A propagation (sample-to-detector) distance
of 95 cm was chosen to produce a sufﬁciently strong bright/
dark fringe from the boundary of each particle, so that they
could be detected amid intensity variations introduced by
overlying tissue and skin. Images were captured using a high-
resolution X-ray converter (AA50 Hamamatsu Photonics)
with a charge-coupled device (CCD) detector. The converter
used a 10 mm-thick scintillator (Lu2SiO5:Ce) to convert X-rays
to visible light, which was then directed to the CCD using a
20 microscope objective lens (NA 0.4). The CCD detector
was a pco.4000 (PCO Imaging) with an array size of 4008 
2672 pixels and a 9 mm  9 mm native pixel size. This set-up
resulted in an effective isotropic pixel size of 0.45 mm and a
ﬁeld of view of 1.8 mm  1.2 mm. The incident beam was
limited to this size using slits to reduce the radiation dose to
the animals. The FWHM of the point spread function, as
determined from an image of a highly attenuating horizontal
edge, was 3.6 mm. Image capture was synchronized with a fast
shutter (Uniblitz XRS6 with VMM-T1 timer unit) and trig-
gered by the ventilator (refer to the animal preparation
description below) to minimize the dose between exposures.
An exposure time of 50 to 80 ms was optimal for capturing
sufﬁcient X-ray photons to ﬁll the potential dynamic range
(214 grey levels) of the detector, providing the maximal signal-
to-noise ratio without inducing detector saturation.
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2.2. Sample preparation
In this experiment four of the particle samples previously
tested in the mouse nasal (Donnelley et al., 2009) and tracheal
airways (Donnelley, Siu et al., 2010) were utilized. Fibreglass
from a commercial pipe insulation and lead sulﬁde (PbS),
present in lead-ore and the primarily component of dust
produced during lead smelting (Spear et al., 1998), were both
ﬁnely ground using a mortar and pestle. Dolomite quarry dust
that settled out of airborne suspension was provided courtesy
of the Boral Resources (SA) Limited Linwood Quarry
(Adelaide, South Australia). Hollow silver-coated glass beads
with a median diameter of 14 mm were obtained from Potter
Industries (Melbourne, Australia) for use as high-visibility
reference particles of known composition, shape and size.
Asbestos was not tested in this experiment as the preparation
of dry asbestos ﬁbres in the imaging hutch was deemed an
unacceptable occupational health and safety hazard. The size
distribution of the samples was determined in a previous study
and typically ranged from 5 mm up to 12 mm diameter with a
small number of larger particles present [see Fig. 3 in
Donnelley, Siu et al. (2010)].
2.3. Animal preparation
The experiment was performed using eight C57Bl/6 mice
weighing 18–20 g. Animal preparation was based on
methods described previously (Donnelley, Parsons et al.,
2010). Mice were anaesthetized with pentobarbital (Somno-
pentil, Pitman-Moore, Washington Crossing, USA, 100 mg
kg1 i.p.). The imaging area around the trachea was cleared of
fur using depilatory cream (Nair, Church & Dwight,
Australia). The mice were intubated using a ﬁbre-optic illu-
minated guide wire and a 20 Ga i.v. catheter (Insyte, Becton
Dickinson, Utah, USA) as an endotracheal (ET) tube
(Hamacher et al., 2008). The ET tube was inserted into the
trachea to a ﬁxed depth of 22.5 mm from the nose tip, placing
the ET tube tip approximately half way between the epiglottis
and the carina, thus avoiding physical perturbation of the
more distal imaging region. The catheter needle-hub was
immediately cut off to minimize respiratory dead-space and so
that the ET tube was ready for connection to the ventilator.
Mice were secured to a polyethylene imaging board with their
dorsal incisors hooked over a stainless-steel wire loop and the
limbs, shoulders and torso taped to the board to minimize
body movements that interfere with high-resolution imaging.
The imaging board was mounted on the hutch sample stage
such that the mouse was oriented supine and the X-ray beam
passed laterally through the mouse trachea, at approximately
ﬁve cartilage rings below the tip of the ET tube. During the
experiment anaesthesia was maintained by constant infusion
of pentobarbital (0.1 mg kg1 s1 via an indwelling i.p. needle)
from a syringe pump (UltraMicroPump III and Micro4
controller, World Precision Instruments, Florida, USA). The
ET tube was attached to a ﬂexiVent small animal ventilator
(SCIREQ, Canada) connected to 100% O2 via a HC100
respiratory humidiﬁer (Fisher and Paykel, Auckland, New
Zealand). Ventilation was set at 80 breaths min1, a tidal
volume of 20 ml kg1 (minute ventilation of approximately
1.6 ml g1) and 3 cm H2O of PEEP. The ventilatory proﬁle
was conﬁgured with Tinspiration = 0.2 s, Tpause = 0.15 s and
Texpiration = 0.4 s (inspiratory-to-expiratory ratio of 87.5%).
The ﬂexiVent provided a trigger to capture a single image
during each end-inspiratory pause. Body temperature was
maintained using an infrared heat lamp and monitored with a
rectal thermometer, and vital signs were monitored using a
MouseOx pulse oximeter (STARR Lifesciences, USA).
2.4. Sample delivery
Owing to the small number of available animals and limited
synchrotron beam time, all mice ﬁrst received hollow silver-
coated glass beads (n = 8). Six of the mice then also received
one of the remaining three particulates (n = 2 per particulate).
After 30 s of baseline collection (40 images) a DP-4 dry
powder insufﬂator and AP-1 air pump (PennCentury, Wynd-
moor, PA, USA) were used to deliver a sample of the hollow
glass beads into the trachea and conducting airways via the ET
tube. Owing to high variability in the output (mass) of the ﬁrst
actuation of the air pump, the ﬁrst output was discarded and
the second actuation was used to deliver the sample to the
airways. The insufﬂator was weighed using a ﬁne balance
before the second actuation and after sample delivery to verify
the mass delivered to the mouse airways. Basing our delivered
doses on mass rather than volume proved to be a precise way
of ensuring that the quantity of each delivered sample was
reliably precise and repeatable. The insufﬂator was thoroughly
cleaned with compressed air between deliveries to remove any
residual particles. After glass beads were delivered, the same
process was used to deliver the second particulate.
To deliver a particulate sample to the mouse airway the
hutch door was opened, the ET tube manually disconnected
from the ﬂexiVent, the sample delivered via the ET tube, the
ﬂexiVent reconnected and the hutch door closed. Typically
there was a delay of 1 min between sample delivery and
imaging. Image acquisition continued for a further 5 min (400
images). A second instillation of particles, i.e. lead, ﬁbreglass
or quarry dust, followed by imaging, created a dataset
consisting of 840 images per mouse.
2.5. Post-experimental analyses
After completion of each experiment, mice were humanely
killed via overdose of pentobarbital (500 mg kg1 i.p.),
without loss of anaesthesia. All image sequences were ﬂat-
ﬁeld and dark-current corrected (Matlab R2010a, The Math-
works, Natick, MA, USA). For high-quality motion-detection
the background must remain still compared with the moving
objects, hence special efforts were made to minimize the
movement of the mouse during imaging, including the use of
restraining boards and respiratory-gating as described. Where
appropriate, speciﬁc details of the image analyses are given in
the ﬁgure legends.
Although it was not the primary goal of the experiment,
50 selected individual non-stationary particles were manu-
ally tracked throughout the image sequences to estimate the
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average MCT rate (mean  standard deviation) of each
particle type when moving. This analysis only measured the
distance particles travelled over time and did not take into
account the pattern of their transit behaviour.
Supplementary movie ﬁles were assembled from the post-
deposition images and show particulate and ﬁbre behaviour
on the tracheal airway surface.1 Each video shows ﬁve minutes
of airway surface activity and consists of 400 frames (one
frame acquired per breath). The movie frame rate is set to
7.5 normal speed. All videos are avi ﬁles, were encoded
using the Xvid codec and can be played using the free VLC
Media Player (available at http://www.videolan.org/vlc/).
3. Results
Using the dry powder insufﬂator 0.1 mg of each particulate
material was delivered to the airways. This corresponded to a
600 greater mass of particulates compared with our
previous study (Donnelley, Siu et al., 2010). Each particulate
type was immediately visible in the PCXI images, but the
majority were stationary when observation began. Fibreglass
and lead were the most clearly visible particles, but glass beads
and a small number of quarry dust particles could also be
detected, particularly once they began to transit the airway
surface. The appearance of the four tested particle types is
shown in Fig. 1. Despite thorough cleaning of the insufﬂator
between each delivery (performed according to the manu-
facturer’s directions), minor cross-contamination was some-
times visible; for example, a single dark lead particle is present
in the ﬁbreglass study (Fig. 1c).
This distance between the X-ray source and the sample on
this beamline is 245 m, so any instabilities in the source (e.g.
electron orbit, optics vibrations owing to thermal or vacuum
instabilities and so on) are exacerbated by a lever arm effect.
This noticeably affected the quality of the acquired images,
particularly the upper (ventral) portion of the trachea. This is
evident in Figs. 1(b) and 1(d) and in the supplementary movies
(a band of rapid intensity ﬂuctuations or ﬂickering, particu-
larly across the top of the image) where the upper tracheal
edge and nearby particles are blurred compared with the same
features on the bottom (dorsal) surface. The exposure length
was also chosen to be sufﬁciently short so as to ensure that
image blurring did not occur; however, we suspect that in
some cases motion of the airway (caused by movement during
the iso-pressure breath hold) did result in some blurring, again
particularly at the ventral tracheal surface.
research papers
554 Martin Donnelley et al.  Dry deposition of pollutant and marker particles J. Synchrotron Rad. (2012). 19, 551–558
Figure 1
All four pollutant and marker particles were visible on the tracheal airway surface. These static frames (taken from each of the four supplementary
movies) show (a) glass beads, (b) lead, (c) ﬁbreglass and (d) quarry dust. Each image contains an inset showing a small segment of the airway surface at
higher magniﬁcation to aid identiﬁcation of the particulates. Each image is 1.8 mm 1.2 mm (insets are0.1 mm 0.1 mm). The head is to the right and
lungs are to the left, with MCTexpected to be predominantly in the left-to-right direction. Note the presence of cartilage bands [broad speckled regions
in (a), (b) and (d)] surrounding the trachea, and the glass beads remaining in (d) from the ﬁrst delivery.
1 Supplementary data for this paper are available from the IUCr electronic
archives (Reference: MO5033). Services for accessing these data are described
at the back of the journal.
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The ﬁrst movement of the particulates in the ﬁeld of view
appeared two to three minutes after delivery. As in previous
studies the particle transit was heterogeneous: after deposition
some particles did not move while others transited the ﬁeld
of view rapidly. In most cases the larger particles moved
substantially less than the smaller particulates. In addition,
many particles did not follow a linear MCT path along the
airway: they followed what appeared to be random circling
paths. In general, particle movement was concentrated along
the dorsal quarter of the tracheal surface. Fig. 2 shows an
example of the movement of lead particles along the dorsal
tracheal surface; artiﬁcial colouring reveals the different rates
and different directions of particle movement. In some
animals radial and axial contraction of the tracheal airway was
also observed within the imaging period (e.g. Fig. 1a). None of
the ﬁbreglass ﬁbres moved after deposition. In contrast, the
glass bead MCTrate was approximately 1.28  0.8 mm min1,
lead was 1.82  1.6 mm min1 and quarry dust was 1.74 
0.8 mm min1.
3.1. Supplementary movie descriptions
The dynamics of airway surface MCT are difﬁcult to
adequately describe or to show in static images, so the four
supplementary movies provided with this paper should be
viewed to best appreciate the nature of particle movement.
These movies demonstrate that particle and ﬁbre visibility is
dramatically enhanced in dynamic sequences when compared
with the static images presented in Fig. 1. The chosen
supplementary movies are representative of the movies
created for each particle type.
There are several details to consider when viewing the
images. Firstly, it is important to note that in these X-ray
images (the static images and movie sequences) particle
activity on both (lateral) tracheal walls is superimposed, so it is
not possible to determine which surface (i.e. near or far) the
particulates are located on. Secondly, some particulates and
particulate motion appears to be located below the apparent
tracheal edge (Figs. 1a and 1c). This phenomenon is due to the
!-shaped dorsal wall of the trachea formed by an epithelial
protrusion in the dorsal surface of the trachea overlying the
trachealis muscles, i.e. the dorsal trachea has a characteristic
centrally ﬂattened ! shape. Thirdly, in all supplementary
movies some remnants of individual fur shafts are also visible
despite depilation and can be identiﬁed as moving with the
overlying skin artefacts.
3.1.1. Supplementary movie 1: hollow glass beads. No
bead movement is visible until approximately frame 40 (30 s
after imaging starts and approximately 90 s after sample
delivery) when the ﬁrst wavefront of massed beads appears
moving toward the mouth (to the right) and extending to
approximately 20% of the tracheal height. The rate of bead
movement varies with time and location along the trachea. At
frame 114 the sample stage was moved so that the bottom
edge of the trachea remained within the ﬁeld of view.
Note that although ‘cilial-like’ activity is present, the
magniﬁcation of structures within these images is orders of
magnitude lower than that required to resolve individual cilia.
We speculate that this optical effect is speckle caused by
refraction of the X-rays through large numbers of small beads
aggregating along the dorsal wall of the trachea as they are
propelled by the underlying massed ciliary actions (Kitchen et
al., 2004).
The entry and movement of beads reveals regions of ciliary
transit patterns, both individual and bulk, that would other-
wise not be apparent. Retrograde, stationary, linear, circular
and stop–start patterns of behaviour are all visible (this effect
is also present for lead particles; see supplementary video 2).
A small number of contaminant lead particles are also visible
ﬂowing in linear and/or circular patterns before stopping.
3.1.2. Supplementary movie 2: lead. Three distinct patterns
of airway surface activity appear to be associated with the lead
particles. Some particles are immobile. On the dorsal surface a
minority of the lead particulates are transported directly along
the trachea towards the head (i.e. to the right). The remainder
(typically 15 mm diameter) appear trapped in an eddy-like
MCT pattern near a substantially larger particle (140 mm,
measured at frame 330). Although less distinct, the movement
of ventral (i.e. located toward the top of the image) particles is
directed obliquely towards the dorsal surface (i.e. the bottom
of the image), with most particles in this case eventually
trapped and left immobile approximately half way down.
3.1.3. Supplementary movie 3: quarry dust. By comparison
with the other supplementary movies [and Figs. 1(a)–1(c)]
only small numbers of quarry dust particles can be seen and
they are less distinct than glass bead or lead particles. Residual
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Figure 2
Artiﬁcially coloured image showing the movement of lead particles on
the airway surface. Three consecutive frames were taken and the intensity
colour map modiﬁed for each such that black (i.e. lowest intensity) was
replaced by red (frame 1), blue (frame 2) and green (frame 3), rendering
the highly attenuating lead particles in each of these colours. The three
frames were then added, so that moving particles could be seen in colour,
with stationary particles seen in black (the sum of red, green and blue). In
the inset the dorsal edge of the trachea is magniﬁed 2 and particles can
be seen moving at different rates and in different directions (as marked)
along the airway surface. The small colour changes surrounding the large
particles represent minor ﬂuctuations from airway movement. As in Fig. 1
the head is to the right and the lungs are to the left. The main image is
1.8 mm  1.2 mm (inset is 0.72 mm  0.24 mm).
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glass beads from the ﬁrst delivery are also apparent along the
left-hand edge of the image moving slowly ventrally then
retrograde (i.e. towards the lung) in the ﬁrst half of the
sequence. Some immobile contaminant dark lead particles are
present along the ventral (upper) tracheal edge. Several
quarry dust particles begin their transit along the dorsal
tracheal edge from the left-hand side at the start of the movie.
In this image series some dust particles leave the dorsal
surface (starting at a point approximately three-quarters
across the frame) and follow a more ventral MCT path.
Towards the end of the sequence other dust particles can be
seen following rotating MCT paths above the dorsal tracheal
surface (approximately half way across the frame). Some
quarry dust particles transit the airway surface and then
disappear.
3.1.4. Supplementary movie 4: fibreglass. Fibres are
immediately obvious, distributed in random orientations,
predominantly along the dorsal (bottom) half of the trachea.
A comparison of the initial and ﬁnal frames showed that in
contrast to the other particle types all the ﬁbres were essen-
tially immobile within the trachea over the imaging period,
regardless of their size. Although the ﬁbres did not move,
some residual bead movement (from the ﬁrst insufﬂation) can
be seen occurring along the dorsal wall until approximately
frame 100.
The mouse was moved (via a motorized sample stage) three
times while images were being captured (at frames 17, 26 and
34) to ensure the bottom edge of the trachea remained within
the ﬁeld of view. Dorsal folds of trachea, apparent as addi-
tional white edges near the bottom of the trachea, are present
centrally and on the right-hand side of the frame [see Figs. 1(a)
and 1(c)]. Again, an unexpected single large lead particle is
present and can be seen rapidly transiting the dorsal wall
before slowing and halting approximately two-thirds across
the frame.
4. Discussion
The primary ﬁnding of this study is that the use of dry particle
insufﬂation greatly improves the ability to detect and to track
particle MCT along live mouse airways using PCXI. Both
pollutant-particle and marker-particle transit was clearly
revealed following dry deposition. Particle transit was more
clearly visible in the dynamic video sequences than the static
images owing to the phenomenon of ‘motion popout’ whereby
moving objects are identiﬁed by retinal motion (Abrams &
Christ, 2003; Rushton et al., 2007). This means that very small
particulates (<5 mm) could be detected provided they were
moving, but were essentially invisible when stationary.
The main strength of this approach is that particulates are
delivered in a more physiologically realistic manner than in
previous experiments. In comparison with our earlier tracheal
deposition studies using a saline carrier ﬂuid (Donnelley, Siu et
al., 2010), dry insufﬂations allowed us to deliver a greater
number of particles and ﬁbres into the trachea, greatly
improving our ability to visualize and describe the MCT
patterns that were present. We expect that most dry particles
are initially deposited on the moist tracheal and conducting
airway surface liquid rather than being washed deeper down
into the conducting airways and lung parenchyma. More
importantly, independent of the increased number of particles,
particle motion was more clearly visible after dry deposition
than after ﬂuid-carrier deliveries (Donnelley, Siu et al., 2010).
We speculate that this might be because dry particles are not
submerged in the carrier ﬂuid and therefore produce stronger
phase-contrast effects on the airway surface, enhancing their
visibility.
The calculated average particle MCTrates (between 1.3 and
1.8 mm min1) were greater than after ﬂuid-carrier particle
delivery [0.37 mm min1 for glass beads, as reported by
Donnelley, Siu et al. (2010)]. We propose that in the ﬂuid-
carrier experiment the addition of the ﬂuid to the airway
surface may have inhibited effective particle MCT during the
imaging period, resulting in slower particle transit rates.
Grubb et al. (2004) determined that bulk mouse tracheal MCT
was 2.2 mm min1 using a dye transit technique, indicating
our ﬁndings are consistent with the existing literature, and
suggesting that dry particle delivery can provide more accu-
rate measurement of the particle MCTrate under synchrotron
PCXI imaging.
The pattern of MCT observed for each particle type was
often different. The appearance of a ‘wavefront’ of small glass
beads that moved along the trachea was not observed for the
other particles. Since the glass beads are hollow they are
readily discernible using PCXI (which enhances boundaries),
and it may be that the large number of delivered small beads
underlies this particular difference. Regardless, our ﬁndings
suggest that hollow glass beads may be a valuable marker
particle for revealing local MCT patterns and for estimating
the local individual and bulk motions of particles being
transported by MCT processes. The glass bead marker particle
behaviour highlights that MCT is not a uniform process as
suggested by radiolabel studies (Grubb et al., 2004), and this
technique may therefore have potential for discovering
mechanisms of toxic pollutant particle and ﬁbre retention,
in addition to their effect on airway health. The frequent
presence of rotating ‘eddy-like’ areas of MCT in intact live
airways that are visible in the supplementary movies could not
be revealed in vivo without the use of these particulates to
visualize the nature of the airway surface activity.
Although we observe particle movement during this short
period, the particulates are by no means completely cleared
from the airways. In many cases particles stopped moving, but
the mechanisms controlling that change in motion cannot be
determined by these studies. Some particles remain in place,
and we interpret these as being held immobile by the surface
mucus forces. However, the function of the MCT mechanisms
is to clear particles, so we speculate that if the imaging period
extended over hours then these immobile particles would
normally be eventually cleared, whether by MCT or by cough
mechanisms. We also speculate that the clearance of ﬁbres
may take substantially longer than the dust particles. Clear-
ance is a two-phase process, with a fast clearance phase that
results in the bulk of the particles being cleared within 24 h,
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and a slow clearance phase that removes additional particles
over a period of multiple days (Falk et al., 1999; Hofmann &
Asgharian, 2003; Mo¨ller et al., 2004). Other studies have
demonstrated the effect of small pollutant particles on lung
tissue several days after exposure (Tong et al., 2006; Zhang
et al., 2007), but little is known about the long-term in vivo
behaviour of deposited particles. In future experiments we
plan to examine particle MCT over a period of days using a
repeated-measures study design.
The prevalence of particles found near the dorsal wall after
dry insufﬂation may be due to the supine positioning of the
mice (i.e. a gravitational effect). Since all ﬁbreglass ﬁbres were
immobile immediately after deposition, the distribution of
ﬁbres towards the dorsal surface suggests that either gravity
or the particle delivery method may inﬂuence the deposition
location. However, in the carrier ﬂuid study most glass beads
were also detected close to the dorsal tracheal wall. In that
study the mice were mounted head-high on the hutch sample
stage, indicating that gravity was unlikely to have played a
signiﬁcant role in that study. This supports the notion that
although gravity may assist deposition along the dorsal surface
it is not the only inﬂuence. Indeed, that common movement of
particles from the ventral to the dorsal regions of the trachea
(see supplementary movie 2) indicates that MCT patterns
drive particles towards the dorsal surface. In future studies we
plan to examine the effects of gravity on particle deposition
patterns and post-deposition MCT behaviour.
The sizes of lead particles detected in the trachea in this dry
deposition study were different from the distribution observed
in the carrier ﬂuid study, despite the samples being drawn from
the same batch of material. We speculate that the density of
the heavy (larger) lead particles caused a rapid settling within
the carrier ﬂuid and prevented them from being drawn up in
the ﬂuid-delivery bolus. Alternatively, if large lead particles
were present in the bolus they were not expelled to the region
of the airway that we imaged. Although our sample size was
small we also did not see clusters of lead particles similar to
those visible in the carrier ﬂuid studies [galena supplementary
video (Donnelley, Siu et al., 2010)].
Substantially more ﬁbreglass was visible after dry insufﬂa-
tion, but as in the carrier ﬂuid study the visible dry-deposited
ﬁbres were immobile throughout the imaging period. We can
only speculate that the ﬁbres may bridge many cilia so that no
net movement can occur, or there is another physical (such as
their long needle-like shape) or chemical property that causes
the ﬁbres to lodge on the airway surface more securely than
for the other particles, possibly increasing their toxicity
compared with generally circular particulates (i.e. dusts). The
inability to effectively clear ﬁbres from the airway might
inﬂuence airway health and warrants further investigation.
Considering that the same mass of each sample was deliv-
ered, we were surprised by the small number of quarry dust
particles present. A proportion of the quarry dust is soluble, so
one explanation is that some dust dissolved after contacting
the wet airway surface, leaving only the insoluble particles
remaining. Fig. 2(b) in our previous study (Donnelley, Siu et
al., 2010) shows that quarry dust is generally less visible than
the other particulates tested, so it is also likely that it is more
difﬁcult to detect in the trachea of live mice. In addition,
because the human visual system excels at detecting moving
particles, it is also possible that the quarry dust was not visible
because many of the dust particles did not move substantially
after deposition, also explaining why those dust particles that
stopped moving seemed to ‘disappear’ from view.
Limitations of this study include the reduced image quality
caused by X-ray beam instability and the movement during
image capture caused by the inability of the ﬂexiVent iso-
pressure breath hold to maintain a completely still trachea. In
future experiments an end-expiratory pause may be combined
with a drug that produces respiratory muscle paralysis to
minimize movement artefacts. Although the frame rate was
higher (1.2 Hz) than for our previous studies (0.1 Hz), it
may still be too low for optimal particle imaging when taking
into account the magniﬁcation and MCT rate of some parti-
cles. With new camera technology we expect that this will
improve in the future. The number of particles visible also
varied despite delivering similar weights to each animal, and
attention to delivering more comparable amounts (e.g.
measuring samples by volume rather than weight) is needed to
improve comparability. It is likely that, because the delivered
quantities are minute and each particulate sample type has
different physicochemical properties (including density,
median diameter, static electricity effects, etc.), they can
behave differently during insufﬂation. Finally, despite thor-
ough cleaning of the insufﬂator some contaminant particulates
were visible in most image sequences. However, these did not
inﬂuence the study outcomes because the contaminants could
be clearly identiﬁed.
In summary, this study veriﬁed that synchrotron PCXI is a
powerful tool for examining the post-deposition MCT beha-
viour of commonly inhaled pollutants after deposition into the
airways of live mice using a dry powder insufﬂator. The use of
a dry delivery system resulted in a greater number of delivered
particles, improved particle visibility and different post-
deposition behaviour than when delivering particles
suspended in a carrier ﬂuid. We propose that the dry delivery
system is also a more physiologically realistic method of
particle delivery, producing particle MCT rates more consis-
tent with the existing literature than our previous wet-delivery
studies. We are continuing with studies to improve our direct
and non-invasive MCT assessment methods to assist our
understanding and treatment of respiratory diseases such
as CF.
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